This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chen, Q. Articles by Yuan, F. Search for Related Content PubMed PubMed Citation Articles by Chen, Q. Articles by Yuan, F.

Departments of ¹ Biomedical Engineering and ² Radiation Oncology, Duke University, Durham, North Carolina

Requests for reprints: Fan Yuan, Department of Biomedical Engineering, Duke University, Box 90281, Durham, NC 27708. Phone: 919-660-5411; Fax: 919-684-4488. E-mail: fyuan{at}duke.edu

Liposomal drugs accumulate only in perivascular regions in tumors after i.v. injection. Thus, they cannot kill tumor cells in deeper tissue layers. To circumvent this problem, we investigated effects of doxorubicin (DOX) encapsulated in a lysolecithin-containing thermosensitive liposome (LTSL) on tumor microcirculation because damaging microvessels would stop nutrient supply to deeper tumor cells. We used LTSL-DOX in combination with hyperthermia to treat a human squamous carcinoma xenograft (FaDu) implanted in dorsal skinfold chambers in nude mice. Before the treatment, the RBC velocity in tumors was 0.428 ± 0.037 mm/s and the microvascular density was 3.93 ± 0.44 mm/mm². At 24 hours after the treatment, they were reduced to 0.003 ± 0.003 mm/s and 0.86 ± 0.27 mm/mm², respectively. The same treatment, however, caused only 32% decrease in the RBC velocity and no apparent change in microvascular networks in normal s.c. tissues over the same period. LTSL and LTSL-DOX alone had no effect on tumor microcirculation, and LTSL plus hyperthermia caused only a transient decrease in the RBC velocity in tumors. At 24 hours after treatments, tumor microcirculation in all these control experiments was insignificantly different from that before the treatments. We also examined apoptosis of cells in tumors at different time points after LTSL-DOX plus hyperthermia treatment and observed few apoptotic cells in tumor microvessels. In conclusion, the rapid release of DOX during hyperthermia could make the drug to shutdown tumor blood flow while have only minor effects on normal microcirculation in s.c. tissues.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

³ Wright AM, Needham D. Evaluation of LTSL-doxorubicin loading and release performance characteristics, manuscript in preparation.

Received 3/ 8/04; revised 7/29/04; accepted 8/20/04.

This article has been cited by other articles:

				N. Yoshida, T. Mita, and M. Onda Susceptibilities of Phospholipid Membranes Containing Cholesterol or Ergosterol to Gramicidin and its Derivative Incorporated in Lysophospholipid Micelles J. Biochem., August 1, 2008; 144(2): 167 - 176. [Abstract] [Full Text] [PDF]

				J. R. MacFall and B. J. Soher From the RSNA Refresher Courses: MR Imaging in Hyperthermia RadioGraphics, November 1, 2007; 27(6): 1809 - 1818. [Abstract] [Full Text] [PDF]

				A. M. Ponce, B. L. Viglianti, D. Yu, P. S. Yarmolenko, C. R. Michelich, J. Woo, M. B. Bally, and M. W. Dewhirst Magnetic Resonance Imaging of Temperature-Sensitive Liposome Release: Drug Dose Painting and Antitumor Effects J Natl Cancer Inst, January 3, 2007; 99(1): 53 - 63. [Abstract] [Full Text] [PDF]